0001012975-16-000929.txt : 20160125
0001012975-16-000929.hdr.sgml : 20160125
20160125164601
ACCESSION NUMBER: 0001012975-16-000929
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20151231
FILED AS OF DATE: 20160125
DATE AS OF CHANGE: 20160125
EFFECTIVENESS DATE: 20160125
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clarus Ventures, LLC
CENTRAL INDEX KEY: 0001431431
IRS NUMBER: 202234539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16028
FILM NUMBER: 161359196
BUSINESS ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-2200
MAIL ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001431431
XXXXXXXX
12-31-2015
12-31-2015
Clarus Ventures, LLC
101 MAIN STREET
SUITE 1210
CAMBRIDGE
MA
02142
13F HOLDINGS REPORT
028-16028
N
Robert W. Liptak
Managing Director
617-949-2200
/s/ Robert W. Liptak
Cambridge
MA
01-25-2016
0
7
142695
false
INFORMATION TABLE
2
clarus.xml
Oxford Immunotec Global PLC
COM
G6855A103
24761
2153092
SH
DFND
2153092
0
0
VBI Vaccines Inc.
COM
91790E102
12129
4971091
SH
DFND
4971091
0
0
Sientra Inc.
COM
82621J105
16166
2730765
SH
DFND
2730765
0
0
Nanostring Technologies Inc.
COM
63009R109
58243
3959440
SH
DFND
3959440
0
0
TetraLogic Pharmaceuticals Corporation
COM
88165U109
8035
4644705
SH
DFND
4644705
0
0
Catabasis Pharmaceuticals Inc.
COM
14875P107
21827
2752488
SH
DFND
2752488
0
0
Aerie Pharmaceuticals Inc.
COM
00771V108
1534
63017
SH
DFND
63017
0
0